Acute Myeloid Leukemia Clinical Trial
Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Summary
The purpose of this study is to determine how effective, and to what extent, Iressa is in the treatment of acute myelogenous leukemia.
Full Description
Patients will receive Iressa daily until either disease progression or intolerable toxicity develops. On Day 1 of treatment, a physical exam and bloodwork will be performed. Once weekly for the first 8 weeks, a physical exam and complete blood count with differential will be performed.
For the first year, a physical exam, bloodwork will be performed monthly. Bone marrow biopsies will be performed after the first month of therapy and then every 3 months for the first year. After the first year a physical exam, bloodwork will be performed every 3 months and bone marrow biopsies every 6 months.
Eligibility Criteria
Inclusion Criteria:
Patients must have pathologically documented acute myelogenous leukemia and either not be a candidate for myelosuppressive chemotherapy due to age or comorbid disease; or have relapsed acute myelogenous leukemia or be refractory to standard therapy and not likely to require cytoreductive therapy within 30 days.
ECOG performance status 0, 1 or 2
Age > 18 years
Adequate kidney and hepatic function
Greater than 4 weeks from any chemotherapy, radiotherapy, immunotherapy, or systemic steroid therapy with the exception of hydroxyurea.
Greater than 2 months following bone marrow or peripheral blood stem cell transplantation or donor lymphocyte infusion.
Exclusion Criteria:
Uncontrolled active infection
Urgent need for cytoreductive chemotherapy, surgery, or radiotherapy
Current chemotherapy or chemotherapy within the last 4 weeks.
Pregnancy or nursing mothers
Infection with HIV
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Boston Massachusetts, 02115, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.